REUTERS/Andrew Kelly/File Photo Acquire Licensing RightsDec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson (BDX.N) is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's (CAH.N) Monoject syringes.
However, the dimensions for Monoject syringes have recently changed while rebranding the syringes from Covidien Monoject to Cardinal Health Monoject.
Last month, the FDA warned healthcare providers not to use Cardinal's Monoject syringes with patient-controlled pain management pumps and syringe pumps after the company initiated a recall due to compatibility problems.
On Sept. 15, BD asked its customers to stop using Cardinal's Monoject syringes with BD's Alaris pumps.
An infusion pump is a medical device that delivers fluids such as nutrients and medications into a patient's body in controlled amounts.
Persons:
Andrew Kelly, Becton Dickinson, Cardinal Health's, Monoject, Health Monoject, BD, Christy Santhosh, Maju Samuel
Organizations:
Food and Drug Administration, FDA, REUTERS, U.S . Food, Drug Administration, Health, Thomson
Locations:
White Oak , Maryland, U.S